Cargando…
Pharmacometrics-Based Considerations for the Design of a Pharmacogenomic Clinical Trial Assessing Irinotecan Safety
PURPOSE: Pharmacometric models provide useful tools to aid the rational design of clinical trials. This study evaluates study design-, drug-, and patient-related features as well as analysis methods for their influence on the power to demonstrate a benefit of pharmacogenomics (PGx)-based dosing rega...
Autores principales: | Minichmayr, Iris K., Karlsson, Mats O., Jönsson, Siv |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057977/ https://www.ncbi.nlm.nih.gov/pubmed/33733372 http://dx.doi.org/10.1007/s11095-021-03024-w |
Ejemplares similares
-
Generation and application of avatars in pharmacometric modelling
por: Chasseloup, Estelle, et al.
Publicado: (2023) -
Assessing Treatment Effects with Pharmacometric Models: A New Method that Addresses Problems with Standard Assessments
por: Chasseloup, Estelle, et al.
Publicado: (2021) -
Generating evidence for precision medicine: considerations made by the Ubiquitous Pharmacogenomics Consortium when designing and operationalizing the PREPARE study
por: van der Wouden, Cathelijne H., et al.
Publicado: (2020) -
Improved Utilization of ADAS-Cog Assessment Data Through Item Response Theory Based Pharmacometric Modeling
por: Ueckert, Sebastian, et al.
Publicado: (2014) -
Adoption of Machine Learning in Pharmacometrics: An Overview of Recent Implementations and Their Considerations
por: Janssen, Alexander, et al.
Publicado: (2022)